This study evaluates the cost-effectiveness and budget impact to US payers of point-of-care nucleic acid amplification tests (NAAT) for group A streptococcus. Objectives: In the United States, ...
Dublin, Feb. 17, 2022 (GLOBE NEWSWIRE) -- The "COVID-19 Nucleic Acid Amplification Tests (NAATs) - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results